Enanta Pharmaceuticals (NASDAQ:ENTA – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “sell” rating to a “hold” rating in a report issued on Thursday. ENTA has been the subject of several other research reports. JPMorgan Chase & Co. lowered shares of Enanta Pharmaceuticals from a “neutral” rating to an “underweight” […]
Enanta Pharmaceuticals, Inc. Expected to Post Q2 2024 Earnings of ($2.61) Per Share (NASDAQ:ENTA) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Jefferies Financial Group cut shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) from a buy rating to a hold rating in a research note released on Tuesday, MarketBeat.com reports. They currently have $18.00 price target on the biotechnology company’s stock, down from their previous price target of $49.00. ENTA has been the topic of a […]
Enanta Pharmaceuticals (NASDAQ:ENTA – Get Free Report) issued an update on its third quarter earnings guidance on Monday morning. The company provided earnings per share guidance of ($1.86) for the period, compared to the consensus earnings per share estimate of ($2.25). The company issued revenue guidance of $18.9 million, compared to the consensus revenue estimate […]
Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) had its price objective reduced by JMP Securities from $65.00 to $42.00 in a research report released on Tuesday morning, MarketBeat reports. JMP Securities currently has a market outperform rating on the biotechnology company’s stock. Other research analysts have also issued research reports about the company. Royal Bank of […]